|
| Register for one of the upcoming UCI NIH Boot Camp Informational Sessions | The Research Development Unit will be hosting three virtual UCI NIH Boot Camp informational sessions. Attend one to learn more about this program and how to apply for the upcoming 2023 UCI NIH Boot Camp! - Thursday, December 15, 2022, 9-10am; register here.
- Wednesday, January 11, 2023, 12-1pm; register here.
- Wednesday, January 25, 2023, 3-4pm; register here.
|
|
| Upper-Division Students from the Data Science Undergraduate Program Available to Help! | Do you have a data science project that could use the help of a group of talented upper-division students from the UCI Data Science undergraduate program? Consider adding it to the Data Science Capstone Project courses, a sequence of two courses that span over two quarters: Winter and Spring 2023. There was great participation and outcomes in previous years with projects from health sciences schools and UCI Health.
Email: Professors Faisal Nawab (CS, nawabf@uci.edu) and Babak Shahbaba (Statistics, babaks@uci.edu) with a brief project description. |
|
| NIH Data Management and Sharing Policy Resources | NIH has released a new Data Management and Sharing Policy, effective Jan. 25, 2023, which requires the submission of a Data Management and Sharing Plan as part of all proposals for research that will generate scientific data. The NIH expects that the data generated will be shared broadly at the conclusion of the research. Researchers should plan now for the rollout of these requirements and develop Data Management and Sharing Plans that meet NIH expectations.
The following resources are available now for developing your plan. - The UCI School of Medicine Office of Research held an informational webinar on Tuesday, November 8. 2022. View the recording and slides.
- The NIH held a two-part webinar series. View the recordings and slide decks here.
- Learn more about this new NIH policy here and in their recent post.
- UCI Libraries has a wealth of resources on their page including the DMPTool and is available for 1:1 consultations.
|
|
| Have You Received a New Award? | | Have you or someone on your research team received a new grant, i.e., research funding? The SOM Office of Research would like to know! Please fill out this short form. |
|
| For the full list of upcoming funding opportunity deadlines: | |
|
| Funding Opportunities Recently Added to Calendar |
| Call for Proposals: Research Seed Funding Program | The 2022-23 UCI Research Seed Funding Program is aimed at investing in promising research directions where internal seed level investment can lead to externally funded “center-scale” research programs. The UCI strategic plan identifies convergence research as one of the keys to achieving the vision of research growth that makes a difference. Here convergence refers to deep integration of knowledge bases, tools, techniques, and ways of thinking from physical sciences, life sciences, engineering, computing and social sciences, and reaching out to humanities, arts, business and law to address major societal challenges. Accordingly, seed funding proposals are invited from multidisciplinary teams that can compete for extramural funding. Please note that the Seed Funding Program is not intended to serve as a funding mechanism for internal UCI-based centers.
Applicants: UCI faculty members who are eligible to serve as Principal Investigators may apply. Only multi-investigator, multi-disciplinary teams and proposals are eligible.
Proposals due: Friday, Jan. 13, 2023
Read more and apply via UCI Review here. |
|
| Testing Centers for Development of Somatic Cell Genome Editing in Model Organisms (U42) (Clinical Trials Not Allowed) (PAR-23-038) | The purpose of this Funding Opportunity Announcement (FOA) is to support Testing Centers for Somatic Cell Genome Editing in several model organisms. Each center will provide resources and testing services, to the growing community developing new genome editing technologies and conducting preclinical testing based upon these technologies, for therapeutics of human diseases. The testing centers will work with NIH funded investigatorsto assess the efficacy and safety of in vivo genome editing and delivery technologies, determine genome editing thresholds for specific diseases associated with minimal off-target effects, and ascertain feasibility parameters in a model system. This data will be important to determine if a treatment strategy using a specific set of tools is effective, has an acceptable safety profile, or if the efficacy and specificity of editing should be significantly improved. Even though each testing center will work on a limited number of focused projects, it is expected that the program and pipeline(s) developed will maintain multifaceted research activities to build core model systems that can be adjusted as required to accommodate a broad spectrum of diseases and provide fee-for-service to the wider biomedical community on a local, regional, and national basis.
Due date: February 1, 2023
View FOA here. |
|
| Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) (RFA-RM-23-003) | Several valuable and widely available data sets have been generated by multiple Common Fund programs. The purpose of this funding opportunity announcement (FOA) is to announce the availability of funding to demonstrate and enhance the utility of selected Common Fund (https://commonfund.nih.gov/) data sets, including generating hypotheses and catalyzing discoveries. Award recipients are asked to provide feedback on the utility of the Common Fund data resources.
Due date: February 3, 2023
View FOA here. |
|
| Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) (PAR-23-025) | This Funding Opportunity Announcement (FOA) solicits applications that propose to conduct time-sensitive ancillary studies related to the NIAMS mission in conjunction with privately or publicly funded, active, ongoing clinical projects (parent projects). The parent project can be an interventional clinical trial, or a clinical study such as an observational study, or a disease-specific repository that will be actively collecting patient samples or clinical data. The parent project(s) should provide a cohort of well-characterized patients, infrastructure, data, and biological samples for the ancillary study. Applications submitted in response to this FOA will undergo an accelerated review and award process. The objective of this FOA is to provide a flexible mechanism to leverage currently funded resources and maximize the return on existing investments in parent projects. Successful ancillary studies will enhance the scientific content and value of the parent projects, improve the research community’s understanding of a disease or organ system in the NIAMS portfolio, and thus may identify novel targets for diagnosis, treatment, and prevention of disease.
Due date: April 06, 2023
Expiration date: December 06, 2025
View FOA here. |
|
| Two Month Reminder: Upcoming Deadlines |
| Upcoming Seminars & Events |
| 2022-2023 Virtual NIH Grants Conference and PreCon Events: Register Now! | Learn about NIH grants policies! Interact with NIH experts! Engage and network with your peers! Gather resources to use and share with colleagues! Register one time to gain access to all virtual preconference events, the 2-day conference, and valuable resources. For more information: https://grants.nih.gov/learning-center/conference
December 2022 – February 2023 |
|
| Human Subjects Research: Policies, Clinical Trials, & Inclusion | Are you working with human subjects in your research and wondering about how HHS regulations and NIH policies apply, how to prepare a research proposal, or how to develop inclusion plans? Join experts from the NIH Division of Human Subjects Research and HHS Office of Human Research Protections (OHRP) for answers to these questions and more.
Wednesday, Dec. 7, 9:00 a.m. to 1:00 p.m. |
|
| Department of Biological Chemistry Seminar Series | Developing combination therapies for combating castration‐resistant prostate cancer
Speaker: Xiaolin Zi, MD, PhD, Professor and Director of Urological Research, Department of Urology, UCI School of Medicine
Date: Wednesday, Dec. 7, 11:00 a.m. to Noon
Location: Plumwood House/Showa Denko Lecture Hall
Event Contact: Barbara Shainerg, bshainbe@hs.uci.edu |
|
| FDA Clinical Investigator Training Course (CITC) | This course is designed to promote professionalism in the clinical trial industry for individuals involved with FDA submissions (Investigational New Drug (IND) Application, New Drug Application (NDA), Biologic License Application (BLA), and Investigational Device Exemption (IDE)), and to familiarize stakeholders with the regulatory and scientific issues involved in the development and approval of medical products. Participants will acquire a practical understanding of FDA’s approach to the evaluation of clinical trials, associated regulatory requirements, and other scientific issues related to investigational medical products. The course is designed for clinical investigators, health care professionals (physicians, nurses, pharmacists, other healthcare workers), and individuals involved in biomedical research and the development of medical products.
Wednesday, Dec. 7, 8:00 a.m. to 12:35 p.m. & Thursday, Dec. 8, 7:45 a.m. to 11:40 a.m. |
|
| MSTP Distinguished Lecture Series | Update of Vascular Cognitive Impairment: Novel Methods and New Studies by Charles DeCarli, MD, FAAN, FAHA, Victor and Genevieve Orsi Chair in Alzheimer's Research; Distinguished Professor of Neurology; Director, Alzheimer's Disease Research Center and Imaging of Dementia and Aging (IDeA) Laboratory, UC Davis School of Medicine
Thursday, Dec. 8, 3:30 to 5:00 p.m.
|
|
| UCI School of Medicine: Virtual Information Session | Learn more about our admissions requirements, interview process, and dual-degree and mission-based programs!
Thursday, Dec. 8, 4:00 p.m. to 5:30 p.m.
Contact: Andrea Gonzalez, andreag1@hs.uci.edu |
|
| Sixth Annual SoCal Genome Stability Symposium | The SoCal Genome Stability Symposium offers postdoctoral associates and graduate students the opportunity to present their current research and to connect with their peers from other laboratories.
Friday, Dec. 9, 8:30 a.m. to 6:30 p.m.
Location: The Cove at UCI Beall Applied Innovation
|
|
| Center for Translational Vision Research (CTVR) Research Seminar: Distinguished Speaker Series | The Nexus of Genes-Aging-Environment in Determining Disease Phenotypes: Lessons from Age-Related Macular Degeneration
Speaker: Anand Swaroop, PhD, Senior Investigator, Neurobiology Neurodegeneration & Repair Laboratory, National Eye Institute (NEI)
Friday, Dec. 9, 8:30 a.m. to 9:30 a.m.
Hybrid Event: In Person, on the 3rd floor of the GHEI building, Cavanaugh Room or via Zoom
Meeting ID: 944 8366 9170, Passcode: 745306 |
|
| Tips and tricks on managing basic science research (early career) | Speakers: Peter Kaiser, PhD, Professor and Chair, Department of Biological Chemistry; Vladimir J. Kefalov, PhD, Professor in the Department of Ophthalmology; Brian J. Cummings, PhD, Associate Dean of Faculty Development, Senate
Monday, Dec. 12, 5:15 p.m. to 6:15 p.m. |
|
| Register for one of the upcoming UCI NIH Boot Camp Informational Sessions | The Research Development Unit will be hosting three virtual UCI NIH Boot Camp informational sessions. Attend one to learn more about this program and how to apply for the upcoming 2023 UCI NIH Boot Camp! - Thursday, December 15, 2022, 9-10am; register here.
- Wednesday, January 11, 2023, 12-1pm; register here.
- Wednesday, January 25, 2023, 3-4pm; register here.
|
|
| What is Research Development? | | Research Development encompasses strategic, proactive, and capacity-building activities designed to support individual faculty and teams of faculty in obtaining extramural research funding and also increase institutional competitiveness. The UCI SOM Research Development Unit (RDU) meets individual faculty to provide information regarding research resources and assistance with grant proposals. Click here to make an appointment. |
|
| Mask Mandate Updated: Masking Recommended But No Longer Required in Indoor, Non-Healthcare Settings | Per the August 19 message from David Souleles, director of the Campus Public Health Response Team, the executive directive on mandatory face coverings has been rescinded effective August 20.
Face coverings are recommended indoors but are not required. Individuals should feel free to continue to wear face coverings, and this protection may be required in some research settings.
The update is consistent with the California Department of Public Health’s recommendations on masking and face coverings.
Please note that masking is still required in all healthcare settings. Face coverings may also be required consistent with public health guidance for a limited duration for those who were COVID-19 positive and returning from isolation, and for those recently exposed to someone with COVID-19. Face coverings are available on campus for all employees and students.
For the latest COVID-19 information, please visit the UCI Forward Website. |
|
| Contribute to Research Insider! |
| |
|
